The expression of YAP1 is increased in high-grade prostatic adenocarcinoma but is reduced in neuroendocrine prostate cancer

BACKGROUND: After long-term androgen deprivation therapy, 25–30% prostate cancer (PCa) acquires an aggressive neuroendocrine (NE) phenotype. Dysregulation of YAP1, a key transcription coactivator of the Hippo pathway, has been related to cancer progression. However, its role in neuroendocrine prosta...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Prostate Cancer Prostatic Dis
Main Authors: Cheng, Siyuan, Prieto-Dominguez, Nestor, Yang, Shu, Connelly, Zachary M., StPierre, Samantha, Rushing, Bryce, Watkins, Andy, Shi, Lawrence, Lakey, Meredith, Baiamonte, Lyndsey Buckner, Fazili, Tajammul, Lurie, Aubrey, Corey, Eva, Shi, Runhua, Yeh, Yunshin, Yu, Xiuping
פורמט: Artigo
שפה:Inglês
יצא לאור: 2020
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7572469/
https://ncbi.nlm.nih.gov/pubmed/32313141
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41391-020-0229-z
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים